Peptide access should not outrun the evidence
In that same study, Omada members reported greater improvements in mental health, physical functioning, and confidence in their ability to lose weight As GLP-1 adoption drives the next era of obesity and cardiometabolic care for millions of Americans, we aim to support the HR professionals and benefits leaders at the forefront of this paradigm shift
Ozempic Black Box Warning The original Ozempic label included a black box warning against use by individuals with personal or family histories of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Mark Geier of Maryland said after meeting with an autistic patient in suburban Chicago
While autoinjectors have streamlined the process, a learning curve remains, and discomfort persists for many
In the STEP-HFpEF trial some of the benefits of semaglutide likely arise from both weight loss-dependent and independent mechanisms